Difference in inflammation, atherosclerosis, and platelet activation between coronary artery aneurysm and coronary

Wei Wei1, Xingxu Wang1, Zhenghao Huang1

  • 1Department of Cardiovascular Medicine, East Hospital, Tongji University School of Medicine, Shanghai, China.

Journal of Thoracic Disease
|November 19, 2020
PubMed

Insights

Coronary artery aneurysm (CAA) is linked to atherosclerosis, while coronary artery ectasia (CAE) is associated with inflammation. Both conditions show platelet activation, suggesting antiplatelet therapy is beneficial for managing these coronary dilatations.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Immunology

Background:

  • Coronary artery aneurysm (CAA) and coronary artery ectasia (CAE) are distinct forms of coronary artery dilatation with unclear origins.
  • Understanding their etiological differences is crucial for effective management.

Purpose of the Study:

  • To compare the distinct characteristics of CAA and CAE.
  • To investigate the underlying pathogenesis of both conditions.
  • To determine the necessity of antiplatelet therapy in patients with CAA and CAE.

Main Methods:

  • A comparative study included 100 patients each with CAA, CAE, and normal coronary arteries (NCA).
  • Evaluated ankle-brachial index (ABI), pulse wave velocity, carotid ultrasonography, and various blood parameters.
  • Assessed vascular inflammatory markers, platelet activation, and aggregation after antiplatelet drug withdrawal.

Main Results:

  • CAE showed elevated inflammatory markers (ANCA, TNF-α, MPO) and endothelial dysfunction.
  • CAA was associated with higher low-density lipoprotein/high-density lipoprotein ratios and carotid artery thickening, indicating atherosclerosis.
  • Both CAA and CAE exhibited increased platelet activation markers and aggregation rates, with specific differences in response to arachidonic acid and adenosine 5'-diphosphate.

Conclusions:

  • CAE pathogenesis is closely linked to inflammation.
  • CAA pathogenesis is closely linked to atherosclerosis.
  • Platelet activation is a common feature in both CAA and CAE, supporting the recommendation for antiplatelet therapy.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
266
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
511
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
221
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
225
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
150
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
175